Mesenchymal stem cell-derived exosomes: a promising alternative in the therapy of preeclampsia

Mesenchymal stem cell-derived exosomes: a promising alternative in the therapy of preeclampsia

Abstract Preeclampsia (PE) is a common morbid complication during pregnancy, affecting 2%-8% of pregnancies globally and posing serous risks to the health of both mother and fetus. Currently, the only effective treatment for PE is timely termination of pregnancy, which comes with increased perinatal...

Full description

Bibliographic Details
Main Authors: Haoran Shi, Zejun Yang, Jianjian Cui, Hui Tao, Ruilin Ma, Yin Zhao
Format: Article
Language:English
Published: BMC 2024-02-01
Series:Stem Cell Research & Therapy
Subjects:
Angiogenesis
Exosomes
Engineered exosomes
Immune regulation
Mesenchymal stem cells
Oxidative stress
Online Access:https://doi.org/10.1186/s13287-024-03652-0

Similar Items

Similar Items